S12.1 Il-16 – a urinary biomarker for proliferative lupus nephritis

S12.1 Il-16 – a urinary biomarker for proliferative lupus nephritis

Bibliographic Details
Main Authors:	V Oke, E Svenungsson, I Gunnarsson, B SUNDELIN, A Zickert, A Larsson, F Faustini, A Häyry
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2022-10-01
Series:	Lupus Science and Medicine

Similar Items

Interleukin (IL) 16: a candidate urinary biomarker for proliferative lupus nephritis
by: Anders Larsson, et al.
Published: (2022-07-01)

Antiphospholipid Antibodies in Lupus Nephritis.
by: Ioannis Parodis, et al.
Published: (2016-01-01)

P10 IL-16 expression in kidney biopsies from patients with SLE- and antiphosholipid syndrome- associated renal thrombotic microangiopathy and renal IgA vasculitis
by: Elisabet Svenungsson, et al.
Published: (2024-03-01)

IFN-λ1 with Th17 axis cytokines and IFN-α define different subsets in systemic lupus erythematosus (SLE)
by: Vilija Oke, et al.
Published: (2017-06-01)

Urinary biomarkers in lupus nephritis
by: Cristian C. Aragón, et al.
Published: (2020-01-01)

O12 Immune complexes containing anti-dsDNA in patients with systemic lupus erythematosus with renal involvement – Association with renal activity and response to treatment
by: Elisabet Svenungsson, et al.
Published: (2024-03-01)

16 Management of lupus nephritis
by: YK Onno Teng
Published: (2023-09-01)

POS-243 THE VALUE OF AUTOANTIBODIES AS PREDICTORS FOR PROLIFERATIVE LUPUS NEPHRITIS CLASSES
by: N. LADHARI, et al.
Published: (2021-04-01)

Autoimmune reactivity to malondialdehyde adducts in systemic lupus erythematosus is associated with disease activity and nephritis
by: Uta Hardt, et al.
Published: (2018-02-01)

A Predictive Model for Estimation Risk of Proliferative Lupus Nephritis
by: Dong-Ni Chen, et al.
Published: (2018-01-01)

Urinary Sediments as Predictors of the Histopathology of Lupus Nephritis
by: Sally M Gamaleldin, et al.
Published: (2022-01-01)

Plasma C4d Correlates With C4d Deposition in Kidneys and With Treatment Response in Lupus Nephritis Patients
by: Myriam Martin, et al.
Published: (2020-10-01)

High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus
by: Vilija Oke, et al.
Published: (2019-04-01)

A Preliminary Predictive Model for Proliferative Lupus Nephritis in Juvenile Systemic Lupus Erythematosus
by: Sern Chin Lim, et al.
Published: (2023-02-01)

Proteome study of cutaneous lupus erythematosus (CLE) and dermatomyositis skin lesions reveals IL-16 is differentially upregulated in CLE
by: Timothy B. Niewold, et al.
Published: (2021-04-01)

O34 Plasma thrombospondin-1 levels are associated with arterial and venous thrombotic events in systemic lupus erythematosus
by: Elisabet Svenungsson, et al.
Published: (2024-03-01)

Long-term renal outcomes of patients with non-proliferative lupus nephritis
by: Eun-Song Kang, et al.
Published: (2023-09-01)

The Steroids in the Maintenance of Remission of Proliferative Lupus Nephritis (SIMPL) Pilot Trial
by: Lauren Galbraith, et al.
Published: (2014-11-01)

Association of Urinary Lipocalin-2 with Lupus Nephritis
by: Farzaneh Sharifipour, et al.
Published: (2013-09-01)

Serum Axl predicts histology-based response to induction therapy and long-term renal outcome in lupus nephritis.
by: Ioannis Parodis, et al.
Published: (2019-01-01)

Renal Tissue Expression of BAFF and BAFF Receptors Is Associated with Proliferative Lupus Nephritis
by: Miguel Marín-Rosales, et al.
Published: (2022-12-01)

Sickle cell nephropathy with diffuse proliferative lupus nephritis: a case report
by: Trivedi Hargovind L, et al.
Published: (2008-02-01)

Urinary CXCL10: a marker of nephritis in lupus patients
by: M. A. Marie, et al.
Published: (2014-03-01)

Differential expression of IFN-α, IL-12 and BAFF on renal immune cells and its relevance to disease activity and treatment responsiveness in patients with proliferative lupus nephritis
by: Yoshiya Tanaka, et al.
Published: (2023-11-01)

Urinary biomarkers associated with podocyte injury in lupus nephritis
by: Zhiying Guo, et al.
Published: (2024-01-01)

Stability of novel urinary biomarkers used for lupus nephritis
by: Ellen M. Cody, et al.
Published: (2022-07-01)

Genetic risk factors in lupus nephritis and IgA nephropathy--no support of an overlap.
by: Mai Tuyet Vuong, et al.
Published: (2010-05-01)

O44 Long-term outcomes of chronic kidney disease patients with lupus nephritis: a nationwide cohort study
by: Iva Gunnarsson, et al.
Published: (2024-03-01)

LP-097 Degranulating PR3+ myeloid cells characterize proliferative lupus nephritis
by: Michelle Petri, et al.
Published: (2023-07-01)

503 Developing a standardized steroid dosing regimen in pediatric proliferative lupus nephritis
by: Hermine I Brunner, et al.
Published: (2021-11-01)

Unexpected recovery from longterm renal failure in severe diffuse proliferative lupus nephritis
by: Ross Sophia, et al.
Published: (2012-08-01)

Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis
by: Chi Chiu Mok, et al.
Published: (2018-01-01)

Management of Lupus Nephritis
by: Farah Tamirou, et al.
Published: (2021-02-01)

Elevated serum levels of human epididymis protein 4 in adult patients with proliferative lupus nephritis
by: Liubing Li, et al.
Published: (2023-05-01)

Diagnostic Determinants of Proliferative Lupus Nephritis Based on Clinical and Laboratory Parameters: A Diagnostic Study
by: Aida Lydia, et al.
Published: (2018-06-01)

Patients with Proliferative Lupus Nephritis Have Autoantibodies That React to Moesin and Demonstrate Increased Glomerular Moesin Expression
by: Dawn J. Caster, et al.
Published: (2021-02-01)

Urinary Long Non-Coding RNA Levels as Biomarkers of Lupus Nephritis
by: Cheuk-Chun Szeto, et al.
Published: (2023-07-01)

IL10 in Lupus Nephritis: Detection and relationship with disease activity
by: Sameh Abou Zeid, et al.
Published: (2015-12-01)

Assessment of the Role of Urinary Heparanase in Lupus Nephritis Patients and Its Correlation with Disease Activity
by: Mustafa A Abou-Alfa, et al.
Published: (2022-01-01)

Urinary monocyte chemoattractant protein-1 as a biomarker of lupus nephritis activity in children
by: Emad E Ghobrial, et al.
Published: (2015-01-01)